Lasker JM[au] - Search Results

Year	Number of Results
1980	1
1981	2
1982	3
1984	1
1985	1
1986	1
1987	4
1988	3
1989	3
1990	1
1991	4
1992	2
1993	5
1994	2
1995	1
1996	5
1998	4
2000	3
2001	2
2002	1
2003	1
2004	1
2005	1
2006	2
2007	3
2008	2
2009	1
2010	1
2011	1
2012	1
2013	1
2022	0

1

Cell-based systems to assess nuclear receptor activation and their use in drug development.

Raucy JL, Lasker JM. Raucy JL, et al. Among authors: lasker jm. Drug Metab Rev. 2013 Feb;45(1):101-9. doi: 10.3109/03602532.2012.737333. Drug Metab Rev. 2013. PMID: 23330544 Review.

2

Bioactivation of halogenated hydrocarbons by cytochrome P4502E1.

Raucy JL, Kraner JC, Lasker JM. Raucy JL, et al. Among authors: lasker jm. Crit Rev Toxicol. 1993;23(1):1-20. doi: 10.3109/10408449309104072. Crit Rev Toxicol. 1993. PMID: 8471158 Review.

3

Current in vitro high throughput screening approaches to assess nuclear receptor activation.

Raucy JL, Lasker JM. Raucy JL, et al. Among authors: lasker jm. Curr Drug Metab. 2010 Nov;11(9):806-14. doi: 10.2174/138920010794328896. Curr Drug Metab. 2010. PMID: 21189134 Review.

4

Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases?

Satarug S, Nishijo M, Lasker JM, Edwards RJ, Moore MR. Satarug S, et al. Among authors: lasker jm. Tohoku J Exp Med. 2006 Mar;208(3):179-202. doi: 10.1620/tjem.208.179. Tohoku J Exp Med. 2006. PMID: 16498227 Free article. Review.

5

Digital-signal-processor-based dynamic imaging system for optical tomography.

Lasker JM, Masciotti JM, Schoenecker M, Schmitz CH, Hielscher AH. Lasker JM, et al. Rev Sci Instrum. 2007 Aug;78(8):083706. doi: 10.1063/1.2769577. Rev Sci Instrum. 2007. PMID: 17764328

6

Utility of DPX2 cells for predicting CYP3A induction-mediated drug-drug interactions and associated structure-activity relationships.

Fahmi OA, Raucy JL, Ponce E, Hassanali S, Lasker JM. Fahmi OA, et al. Among authors: lasker jm. Drug Metab Dispos. 2012 Nov;40(11):2204-11. doi: 10.1124/dmd.112.047456. Epub 2012 Aug 21. Drug Metab Dispos. 2012. PMID: 22912432

7

Purification and characterization of human liver cytochrome P-450-ALC.

Lasker JM, Raucy J, Kubota S, Bloswick BP, Black M, Lieber CS. Lasker JM, et al. Biochem Biophys Res Commun. 1987 Oct 14;148(1):232-8. doi: 10.1016/0006-291x(87)91100-4. Biochem Biophys Res Commun. 1987. PMID: 3675576

8

In vivo activation of zoxazolamine metabolism by flavone.

Lasker JM, Huang M-T, Conney AH. Lasker JM, et al. Science. 1982 Jun 25;216(4553):1419-21. doi: 10.1126/science.7089530. Science. 1982. PMID: 7089530

9

Comparison of new methods for measuring carbohydrate-deficient transferrin (CDT): application to a public health approach for the prevention of alcoholic cirrhosis.

Lieber CS, Xin Y, Lasker JM, Rosman AS. Lieber CS, et al. Among authors: lasker jm. Alcohol Alcohol Suppl. 1993;2:111-6. Alcohol Alcohol Suppl. 1993. PMID: 7748286 Review.

10

Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol.

Bornheim LM, Lasker JM, Raucy JL. Bornheim LM, et al. Among authors: lasker jm. Drug Metab Dispos. 1992 Mar-Apr;20(2):241-6. Drug Metab Dispos. 1992. PMID: 1352216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results